+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Irritable Bowel Syndrome Treatment Market By Product (Constella/Linzess, Amitiza, Xifaxan, Viberzi, and Others) and Product (IBS-D and IBS-C): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

  • ID: 5143516
  • Report
  • November 2019
  • Region: Global
  • 110 pages
  • Zion Market Research

Enquire about COVID-19 updates for this product.

Enquire Now
The report covers forecast and analysis for the irritable bowel syndrome treatment market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the irritable bowel syndrome treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the irritable bowel syndrome treatment market on a global as well as regional level.

According to the report, global demand for irritable bowel syndrome treatment market was valued at approximately USD 1,562.4 Million in 2018, and is expected to generate revenue of around USD 3,085.0 Million by end of 2025, growing at a CAGR of around 10.3% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the irritable bowel syndrome treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the irritable bowel syndrome treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the irritable bowel syndrome treatment market on global and regional basis.

Irritable Bowel Syndrome (IBS) is a disorder that disturbs the large intestine. The symptoms of IBS comprise abdominal pain, cramping, gas, constipation or diarrhea, and bloating. IBS management is a long term process. Mild symptoms can be controlled by handling lifestyle, diet, and stress. However, severe symptoms require counseling and medication. IBS with diarrhea (IBS-D) and IBS with constipation (IBS-C) are two major types of IBS.

Factors such as increasing prevalence of IBS, growing use of medication for the treatment of IBS, increasing commercialization of available drugs in multiple regions, and increasing trend of unhealthy lifestyle will act as major driving factors in the growth of global irritable bowel syndrome treatment market. Launch of new products and investment in research and development will act as an opportunity for the market players in the irritable bowel syndrome treatment market. Nonetheless, lack of awareness and dearth of skilled physicians in low-income countries will restrict the growth of global irritable bowel syndrome treatment market.

The global irritable bowel syndrome treatment market has been split into product, type, and region. Based on product, irritable bowel syndrome treatment market has been segmented into constella/linzess, amitiza, xifaxan, viberzi, and others. The constella/linzess segment accounted for the highest market share in 2018 due to increasing acceptance of the product. The type segment has been segmented into IBS-D and IBS-C. The IBS-C segment accounted for the highest market share in 2018 due to high prevalence of IBS-C. IBS-D has been divided into viberzi, xifaxan, and others. IBS-C has been divided into amitiza, constella/linzess, and others.

North America will be the leading region during the forecast period. Presence of major companies, presence of modern healthcare infrastructure, and availability of novel treatment options will boost the market growth in this region. Europe is expected to be the second major market. The key reasons are presence of skilled physicians and high healthcare expenditure. Asia Pacific will grow at rapid rate over the forecast time-frame due to launch of novel products, increasing patient awareness, growing government initiatives. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

The report also includes detailed profiles of key players such as Allergan, Ironwood Pharmaceuticals, Inc., Astellas Pharma, Inc., AstraZeneca, Takeda Pharmaceutical Company Limited, Synergy Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Ardelyx, Synthetic Biologics, Inc., and Bausch Health among others.

This report segments the Global Irritable Bowel Syndrome Treatment Market as follows:

Global Irritable Bowel Syndrome Treatment Market: By Product
  • Constella/Linzess
  • Amitiza
  • Xifaxan
  • Viberzi
  • Others
Global Irritable Bowel Syndrome Treatment Market: By Product
  • IBS-D
  • Viberzi
  • Xifaxan
  • Others
  • IBS-C
  • Amitiza
  • Constella/Linzess
  • Others
Global Irritable Bowel Syndrome Treatment Market: By Region
  • North America
  • The U.S.
  • Canada
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
    • 2.2. Irritable Bowel Syndrome Treatment Market: Snapshot
  • Chapter 3. Irritable Bowel Syndrome Treatment Market – Industry Analysis
    • 3.1. Irritable Bowel Syndrome Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of IBS
      • 3.2.2. Growing use of medication for the treatment of IBS
    • 3.3. Restraints
      • 3.3.1. Lack of awareness
      • 3.3.2. Dearth of skilled physicians
    • 3.4. Opportunities
      • 3.4.1. Launch of new products
      • 3.4.2. Investment in research and development
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Type
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Irritable Bowel Syndrome Treatment Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Irritable Bowel Syndrome Treatment Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Irritable Bowel Syndrome Treatment Market –Product Analysis
    • 5.1. Global Irritable Bowel Syndrome Treatment Market overview: By Product
      • 5.1.1. Global Irritable Bowel Syndrome Treatment Market share, By Product,2018 and 2025
    • 5.2. Constella/Linzess
      • 5.2.1. Global Irritable Bowel Syndrome Treatment Market by Constella/Linzess, 2016–2025 (USD Billion)
    • 5.3. Amitiza
      • 5.3.1. Global Irritable Bowel Syndrome Treatment Market by Amitiza, 2016–2025 (USD Billion)
    • 5.4. Xifaxan
      • 5.4.1. Global Irritable Bowel Syndrome Treatment Market by Xifaxan, 2016–2025 (USD Billion)
    • 5.5. Viberzi
      • 5.5.1. Global Irritable Bowel Syndrome Treatment Market by Viberzi, 2016–2025 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Irritable Bowel Syndrome Treatment Market by Others, 2016–2025 (USD Billion)
  • Chapter 6. Global Irritable Bowel Syndrome Treatment Market –Type Analysis
    • 6.1. Global Irritable Bowel Syndrome Treatment Market overview: By Type
      • 6.1.1. Global Irritable Bowel Syndrome Treatment Market share, By Type, 2018 and 2025
    • 6.2. IBS-D
      • 6.2.1. Global Irritable Bowel Syndrome Treatment Market By IBS-D, 2016–2025 (USD Billion)
    • 6.3. IBS-C
      • 6.3.1. Global Irritable Bowel Syndrome Treatment Market By IBS-C, 2016–2025 (USD Billion)
  • Chapter 7. Global Irritable Bowel Syndrome Treatment Market - Regional Analysis
    • 7.1. Global Irritable Bowel Syndrome Treatment Market overview: by Region
      • 7.1.1. Global Irritable Bowel Syndrome Treatment Market share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
      • 7.2.2. North America Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
      • 7.2.3. North America Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.2.4.2. U.S. Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.2.5.2. Rest of North America Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
      • 7.3.2. Europe Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
      • 7.3.3. Europe Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. UK Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.3.4.2. UK Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.3.5.2. France Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.3.6.2. Germany Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.3.7.2. Rest of Europe Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
      • 7.4.2. Asia Pacific Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
      • 7.4.3. Asia Pacific Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.4.4.2. China Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.4.5.2. Japan Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.4.6.2. India Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
      • 7.5.2. Latin America Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
      • 7.5.3. Latin America Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.5.4.2. Brazil Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
        • 7.5.5.2. Rest of Latin America Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Irritable Bowel Syndrome Treatment Market, 2016–2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Irritable Bowel Syndrome Treatment Market revenue, By Product,2016–2025 (USD Billion)
      • 7.6.3. The Middle East and Africa Irritable Bowel Syndrome Treatment Market revenue, By Type, 2016–2025 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Allergan
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Ironwood Pharmaceuticals, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Astellas Pharma, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. AstraZeneca
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Takeda Pharmaceutical Company Limited
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Synergy Pharmaceuticals Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Sebela Pharmaceuticals Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Ardelyx
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Synthetic Biulogics, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Bausch Health
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
Note: Product cover images may vary from those shown
Adroll
adroll